IS SERUM ANHYDROGLUCITOL AN ALTERNATIVE TO THE ORAL GLUCOSE-TOLERANCE TEST FOR DIABETES SCREENING

被引：29

作者：

ROBERTSON, DA ^{[1
]}

ALBERTI, KGMM ^{[1
]}

DOWSE, GK ^{[1
]}

ZIMMET, P ^{[1
]}

TUOMILEHTO, J ^{[1
]}

GAREEBOO, H ^{[1
]}

机构：

[1] HUMAN DIABET & METAB RES CTR,NEWCASTLE TYNE,ENGLAND

来源：

DIABETIC MEDICINE | 1993年 / 10卷 / 01期

关键词：

ANHYDROGLUCITOL; DEOXYGLUCOSE; DIABETES; SCREENING; DIAGNOSTIC TESTS; FRUCTOSAMINE; ORAL GLUCOSE TOLERANCE TEST;

D O I：

10.1111/j.1464-5491.1993.tb01997.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The oral glucose tolerance test is inconvenient for diabetes screening. In clinical studies a reduced serum anhydroglucitol level has proved to be a sensitive and specific test for diabetes. A new minicolumn enzymatic method which is simple and robust makes use in population screening feasible. The aim of our study was to assess the usefulness of a single measurement of anhydroglucitol to screen for diabetes and impaired glucose tolerance. Assays were performed on samples taken from 227 Mauritian Chinese subjects at the time of glucose tolerance testing. Subjects had normal glucose tolerance (n = 82), impaired glucose tolerance (n = 76), newly diagnosed diabetes (n = 38), and known diabetes (n = 31). Anhydroglucitol concentrations (mean +/- SD) were similar for normal and impaired glucose tolerance subjects (23.7 +/- 8.2 vs 23.4 +/- 8.6 mg l-1). Although the differences between normal and newly diagnosed diabetes (15.0 +/- 11.0 mg l-1) and known diabetic subjects (11.8 +/- 10.6 mg 1-1) were significant (p < 0.001), diagnostic sensitivity and specificity were poor. We conclude that measurement of serum anhydroglucitol is not suitable for screening for the diagnoses of impaired glucose tolerance and diabetes.

引用

页码：56 / 60

页数：5

共 33 条

[1]

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 28, pp. 1039-1057, (1979)

[2]

Diabetes Mellitus, pp. 10-12, (1985)

[3]

Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM, Impaired glucose tolerance, Br Med J, 301, pp. 397-402, (1990)

[4]

Swai ABM, Harrison K, Chuwa LM, Makene W, McLarty DG, Alberti KGMM, Screening for diabetes: Does measurement of serum fructosamine help?, Diabetic Med, 5, pp. 648-652, (1988)

[5]

Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN, Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus, Br Med J, 287, pp. 863-867, (1983)

[6]

Albutt EC, Nattrass M, Northam BE, Glucose tolerance test and glycosylated haemoglobin measurement for diagnosis of diabetes mellitus—an assessment of the criteria of the WHO Expert Committee on diabetes mellitus 1980, Ann Clin Biochem, 22, pp. 67-73, (1985)

[7]

Forrest RD, Jackson CA, Yudkin JS, The glycohaemoglobin assay as a screening test for diabetes mellitus: The Islington Diabetes Survey, Diabetic Med, 4, pp. 254-259, (1987)

[8]

Little RR, England JD, Wiedmeyer H-M, Mckenzie EM, Pettitt DJ, Knowler WC, Et al., Relationship of glycosylated haemoglobin to oral glucose tolerance. Implications for diabetes screening, Diabetes, 37, pp. 60-64, (1988)

[9]

Forrest RD, Jackson CA, Gould BJ, Casburn-Budd M, Taylor JE, Yudkin JS, Four assay methods for glycated hemoglobin compared as screening test for diabetes mellitus: The Islington diabetes survey, Clin Chem, 34, pp. 145-148, (1988)

[10]

Modan M, Halkin H, Karasik A, Lusky A, Effectiveness of glycosylated hemoglobin, fasting plasma glucose and a single post load plasma glucose level in population screening for intolerance: the Israel study of glucose intolerance and hypertension, Am J Epidemiol, 119, pp. 431-444, (1984)

← 1 2 3 4 →